The Europe pulmonary drug delivery market is anticipated to grow with a CAGR of 4.62%, across the forecast years of 2019 to 2028. The rising prevalence of respiratory conditions and the efforts established by the government and non-profit organizations are attributed to the region’s market growth. The Europe pulmonary drug delivery market growth analysis includes the assessment of the United Kingdom, Russia, Italy, Germany, France, Poland, Belgium, and the rest of Europe.
EUROPE PULMONARY DRUG DELIVERY MARKET FORECAST 2019-2028
Europe Pulmonary Drug Delivery Market by Application (Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Cystic Fibrosis, Other Applications) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce) by End-user (Hospitals & Clinics, Homecare) by Product (Metered Dose Inhalers, Dry Powder Inhalers, Nebulizer (Pneumatic Nebulizer (Breath Actuated Pneumatic Nebulizer, Vented Pneumatic Nebulizer), Mesh Nebulizer (Vibrating Mesh Nebulizer, Static Mesh Nebulizer), Ultrasonic Nebulizer), Accessories) and by Geography.
The Europe pulmonary drug delivery market is anticipated to grow with a CAGR of 4.62%, across the forecast years of 2019 to 2028. The rising prevalence of respiratory conditions and the efforts established by the government and non-profit organizations are attributed to the region’s market growth.
To know more about this report, request a free sample copy
The Europe pulmonary drug delivery market growth analysis includes the assessment of the United Kingdom, Russia, Italy, Germany, France, Poland, Belgium, and the rest of Europe. According to Asthma UK, over 5 million people have asthma in the United Kingdom. It also means that the condition affects one in eleven people, and one in five households. Moreover, in 2016, over 1400 people died from the respiratory condition in the United Kingdom. Likewise, according to the British Lung Foundation, more than 1 million people are diagnosed with chronic obstructive pulmonary disease (COPD), and over 1.5 million people are detected for interstitial lung disease. At least one-fourth of the overall hospital admissions, particularly for respiratory disorders, are caused by smoking.
In September 2016, the National Health Service (NHS) England launched an essential update for national guidance, focusing on managing asthma, providing effective treatments for the condition, and preventing dangerous asthma attacks. Moreover, numerous non-profit organizations, like the British Lung Foundation, striving to provide funds and educate the masses regarding the best treatment options for lung conditions, are also bolstering the market growth.
AstraZeneca PLC, a holding company, headquartered in the United Kingdom, operates through its subsidiaries, and researches, manufactures, and commercializes medical and pharmaceutical products. Its operations include therapeutic avenues such as, respiratory, cardiovascular, oncology, pain control, central nervous system, and infection, among others.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- PARENT MARKET ANALYSIS: DRUG DELIVERY MARKET
- DEVELOPMENT OF DRUG DELIVERY SYSTEM
- MARKET DEFINITION
- KEY DRIVERS
- GROWING PREVALENCE OF RESPIRATORY DISEASE
- ADVANCEMENTS IN TECHNOLOGY
- RISING GERIATRIC POPULATION
- KEY RESTRAINTS
- STRINGENT REGULATION AND PATENT EXPIRY
- INCREASING DRUG RECALLS AND DRUG FAILURES
- SIDE EFFECTS AND RISK ASSOCIATED WITH THE DRUGS
- KEY ANALYTICS
- PORTER’S FIVE FORCE ANALYSIS
- THREAT OF NEW ENTRY
- THREAT OF SUBSTITUTION
- BUYER’S POWER
- SUPPLIER’S POWER
- COMPETITIVE RIVALRY
- REGULATORY FRAMEWORK
- IMPACT OF COVID-19 ON PULMONARY DRUG DELIVERY MARKET
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY INVESTMENT INSIGHTS
- PORTER’S FIVE FORCE ANALYSIS
- MARKET BY APPLICATION
- ASTHMA
- CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- ALLERGIC RHINITIS
- CYSTIC FIBROSIS
- OTHER APPLICATIONS
- MARKET BY DISTRIBUTION CHANNEL
- HOSPITAL PHARMACIES
- RETAIL PHARMACIES
- E-COMMERCE
- MARKET BY END-USER
- HOSPITALS & CLINICS
- HOMECARE
- MARKET BY PRODUCT
- METERED DOSE INHALERS
- DRY POWDER INHALERS
- NEBULIZER
- PNEUMATIC NEBULIZER
- MESH NEBULIZER
- ULTRASONIC NEBULIZER
- ACCESSORIES
- GEOGRAPHICAL ANALYSIS
- EUROPE
- GERMANY
- THE UNITED KINGDOM
- FRANCE
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- EUROPE
- COMPANY PROFILES
- 3M COMPANY
- ACTELION PHARMACEUTICALS LTD
- AEROGEN
- AGILENT TECHNOLOGIES INC
- ASTRAZENECA PLC
- BOEHRINGER INGELHEIM GMBH
- CLEMENT CLARKE INTERNATIONAL
- GF HEALTH PRODUCTS INC
- GLAXOSMITHKLINE PLC
- KONINKLIJKE PHILIPS NV
- MERCK & CO INC
- NOVARTIS AG
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- VECTURA GROUP PLC
TABLE LIST
TABLE 1: MARKET SNAPSHOT – PULMONARY DRUG DELIVERY
TABLE 2: EUROPE PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: EUROPE PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: EUROPE PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: EUROPE PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: EUROPE PULMONARY DRUG DELIVERY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: EUROPE PULMONARY DRUG DELIVERY MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: EUROPE PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: EUROPE PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: EUROPE NEBULIZER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: EUROPE NEBULIZER MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: EUROPE PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: EUROPE PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
FIGURES LIST
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: OPPORTUNITY MATRIX
FIGURE 3: VENDOR LANDSCAPE
FIGURE 4: KEY INVESTMENT INSIGHTS
FIGURE 5: EUROPE PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, IN 2019
FIGURE 6: EUROPE PULMONARY DRUG DELIVERY MARKET, BY ASTHMA, 2019-2028 (IN $ MILLION)
FIGURE 7: EUROPE PULMONARY DRUG DELIVERY MARKET, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019-2028 (IN $ MILLION)
FIGURE 8: EUROPE PULMONARY DRUG DELIVERY MARKET, BY ALLERGIC RHINITIS, 2019-2028 (IN $ MILLION)
FIGURE 9: EUROPE PULMONARY DRUG DELIVERY MARKET, BY CYSTIC FIBROSIS, 2019-2028 (IN $ MILLION)
FIGURE 10: EUROPE PULMONARY DRUG DELIVERY MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
FIGURE 11: EUROPE PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, IN 2019
FIGURE 12: EUROPE PULMONARY DRUG DELIVERY MARKET, BY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 13: EUROPE PULMONARY DRUG DELIVERY MARKET, BY RETAIL PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 14: EUROPE PULMONARY DRUG DELIVERY MARKET, BY E-COMMERCE, 2019-2028 (IN $ MILLION)
FIGURE 15: EUROPE PULMONARY DRUG DELIVERY MARKET, BY END-USER, IN 2019
FIGURE 16: EUROPE PULMONARY DRUG DELIVERY MARKET, BY HOSPITALS & CLINICS, 2019-2028 (IN $ MILLION)
FIGURE 17: EUROPE PULMONARY DRUG DELIVERY MARKET, BY HOMECARE, 2019-2028 (IN $ MILLION)
FIGURE 18: EUROPE PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, IN 2019
FIGURE 19: EUROPE PULMONARY DRUG DELIVERY MARKET, BY METERED DOSE INHALERS, 2019-2028 (IN $ MILLION)
FIGURE 20: EUROPE PULMONARY DRUG DELIVERY MARKET, BY DRY POWDER INHALERS, 2019-2028 (IN $ MILLION)
FIGURE 21: EUROPE PULMONARY DRUG DELIVERY MARKET, BY NEBULIZER, 2019-2028 (IN $ MILLION)
FIGURE 22: EUROPE NEBULIZER MARKET, BY PNEUMATIC NEBULIZER, 2019-2028 (IN $ MILLION)
FIGURE 23: EUROPE NEBULIZER MARKET, BY MESH NEBULIZER, 2019-2028 (IN $ MILLION)
FIGURE 24: EUROPE NEBULIZER MARKET, BY ULTRASONIC NEBULIZER, 2019-2028 (IN $ MILLION)
FIGURE 25: EUROPE PULMONARY DRUG DELIVERY MARKET, BY ACCESSORIES, 2019-2028 (IN $ MILLION)
FIGURE 26: EUROPE PULMONARY DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE 27: GERMANY PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
FIGURE 28: THE UNITED KINGDOM PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
FIGURE 29: FRANCE PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
FIGURE 30: ITALY PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
FIGURE 31: RUSSIA PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
FIGURE 32: BELGIUM PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
FIGURE 33: POLAND PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
FIGURE 34: REST OF EUROPE PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- GERMANY
- THE UNITED KINGDOM
- FRANCE
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- EUROPE
- MARKET BY APPLICATION
- ASTHMA
- CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- ALLERGIC RHINITIS
- CYSTIC FIBROSIS
- OTHER APPLICATIONS
- MARKET BY DISTRIBUTION CHANNEL
- HOSPITAL PHARMACIES
- RETAIL PHARMACIES
- E-COMMERCE
- MARKET BY END-USER
- HOSPITALS & CLINICS
- HOMECARE
- MARKET BY PRODUCT
- METERED DOSE INHALERS
- DRY POWDER INHALERS
- NEBULIZER
- PNEUMATIC NEBULIZER
- MESH NEBULIZER
- ULTRASONIC NEBULIZER
- ACCESSORIES
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.